miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGFβRΙ and inhibiting the activation of Smad-2/3 pathway
- PMID: 35322290
- DOI: 10.1007/s10863-022-09934-7
miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGFβRΙ and inhibiting the activation of Smad-2/3 pathway
Abstract
Objective: Atrial fibrillation (AF) is a major cause of stroke with lifetime risks. microRNAs (miRNAs) are associated with AF attenuation, yet the mechanism remains unknown. This study investigated the functional mechanism of miR-29b in atrial fibrosis in AF.
Methods: The AF rat model was established by a 7-day intravenous injection of Ach-CaCl2 mixture. AF rats were injected with adeno-associated virus (AAv)-miR-29b and TGFβRΙ overexpression plasmid. AF duration was recorded by electrocardiogram. Atrial fibrosis was observed by Masson staining. Expressions of COL1A1, COL3A1, TGFβRΙ, TGFβΙ, miR-29b and Smad-2/3 pathway-related proteins in atrial tissues were detected by RT-qPCR and Western blot. Binding sites of miR-29b and TGFβRΙ were predicted and their target relationship was verified by dual-luciferase reporter assay.
Results: miR-29b was poorly expressed and expressions of COL1A1, COL3A1, TGFβRΙ, and TGFβ1 were increased in atrial tissues of AF rats. miR-29b overexpression alleviated atrial fibrosis, reduced expressions of COL1A1, COL3A1, and TGFβ1, and shortened AF duration in AF rats. TGFβRΙ was highly expressed in atrial tissues of AF rats. miR-29b targeted TGFβRΙ. TGFβRΙ overexpression overcame the improving effect of miR-29b overexpression on AF. miR-29b overexpression decreased ratios of p-Smad-2/3 and Smad-2/3 and inhibited the Smad-2/3 pathway.
Conclusion: miR-29b might mitigate atrial fibrosis in AF rats by targeting TGFβRΙ and inhibiting the Smad-2/3 pathway.
Keywords: Atrial fibrillation; Atrial fibrosis; COL1A1, COL3A1; Smad-2/3; TGFβ1; TGFβRΙ; miR-29b.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/β-Catenin and Attenuates Atrial Fibrosis in Rats with Atrial Fibrillation.Oxid Med Cell Longev. 2019 Apr 17;2019:5703764. doi: 10.1155/2019/5703764. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31178968 Free PMC article.
-
Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5.Hum Cell. 2018 Jul;31(3):251-260. doi: 10.1007/s13577-018-0208-z. Epub 2018 Apr 18. Hum Cell. 2018. PMID: 29671258
-
miR‑101a‑3p overexpression prevents acetylcholine‑CaCl2‑induced atrial fibrillation in rats via reduction of atrial tissue fibrosis, involving inhibition of EZH2.Mol Med Rep. 2021 Oct;24(4):740. doi: 10.3892/mmr.2021.12380. Epub 2021 Aug 26. Mol Med Rep. 2021. PMID: 34435649 Free PMC article.
-
The role of SGLT1 in atrial fibrillation and its relationship with endothelial-mesenchymal transition.Biochem Biophys Res Commun. 2025 Feb 8;748:151338. doi: 10.1016/j.bbrc.2025.151338. Epub 2025 Jan 13. Biochem Biophys Res Commun. 2025. PMID: 39823893 Review.
-
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation.Int J Mol Sci. 2023 Mar 10;24(6):5307. doi: 10.3390/ijms24065307. Int J Mol Sci. 2023. PMID: 36982382 Free PMC article. Review.
Cited by
-
MicroRNAs in atrial fibrillation - have we discovered the Holy Grail or opened a Pandora's box?Front Pharmacol. 2025 Feb 12;16:1535621. doi: 10.3389/fphar.2025.1535621. eCollection 2025. Front Pharmacol. 2025. PMID: 40012622 Free PMC article. Review.
-
Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies.Mol Cell Biochem. 2024 Nov;479(11):2827-2841. doi: 10.1007/s11010-023-04895-w. Epub 2023 Dec 8. Mol Cell Biochem. 2024. PMID: 38064139 Free PMC article. Review.
-
Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway.Front Pharmacol. 2023 Feb 9;14:1092148. doi: 10.3389/fphar.2023.1092148. eCollection 2023. Front Pharmacol. 2023. PMID: 36843918 Free PMC article. Review.
-
MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1.Mol Biol Rep. 2023 Dec;50(12):9757-9767. doi: 10.1007/s11033-023-08755-0. Epub 2023 Sep 7. Mol Biol Rep. 2023. PMID: 37676431 Free PMC article.
-
Noncoding RNAs and Cardiac Fibrosis.Rev Cardiovasc Med. 2023 Feb 14;24(2):63. doi: 10.31083/j.rcm2402063. eCollection 2023 Feb. Rev Cardiovasc Med. 2023. PMID: 39077397 Free PMC article. Review.
References
-
- Abdullah AS, El Sayed IET, El-Torgoman AMA, Alghamdi NA, Ullah S, Wageh S et al (2021) Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets. Biomedicines 9(12). https://doi.org/10.3390/biomedicines9121767
-
- Abonnenc M, Nabeebaccus AA, Mayr U, Barallobre-Barreiro J, Dong X, Cuello F et al (2013) Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res 113(10):1138–1147. https://doi.org/10.1161/CIRCRESAHA.113.302400 - DOI - PubMed
-
- Andrade J, Khairy P, Dobrev D, Nattel S (2014) The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 114(9):1453–1468. https://doi.org/10.1161/CIRCRESAHA.114.303211 - DOI - PubMed
-
- Andrade JG, Macle L, Nattel S, Verma A, Cairns J (2017) Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines. Can J Cardiol 33(8):965–976. https://doi.org/10.1016/j.cjca.2017.06.002 - DOI - PubMed
-
- Bencivenga L, Komici K, Nocella P, Grieco FV, Spezzano A, Puzone B et al (2020) Atrial fibrillation in the elderly: a risk factor beyond stroke. Ageing Res Rev 61:101092. https://doi.org/10.1016/j.arr.2020.101092 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous